F, K., S, A., K, O., A, F., A, K., & S, A. (2026). Deoxynojirimycin derivatives as potent α-glucosidase inhibitors: In silico ADMET evaluation, molecular dynamics and in vitro validation studies. Molecular diversity, 30(3), 3543. https://doi.org/10.1007/s11030-025-11307-2
Chicago Style (17th ed.) CitationF, Khan, Ahmad S, Osama K, Farooqui A, Kumar A, and Akhtar S. "Deoxynojirimycin Derivatives as Potent α-glucosidase Inhibitors: In Silico ADMET Evaluation, Molecular Dynamics and in Vitro Validation Studies." Molecular Diversity 30, no. 3 (2026): 3543. https://doi.org/10.1007/s11030-025-11307-2.
MLA (9th ed.) CitationF, Khan, et al. "Deoxynojirimycin Derivatives as Potent α-glucosidase Inhibitors: In Silico ADMET Evaluation, Molecular Dynamics and in Vitro Validation Studies." Molecular Diversity, vol. 30, no. 3, 2026, p. 3543, https://doi.org/10.1007/s11030-025-11307-2.